Archives
Alcohol Use Disorder, Alcohol-Associated Liver Disease Up in Older U.S. Adults
Despite global decreases, prevalence and mortality increased in United States
Antibiotics for Seven Days Noninferior for Bloodstream Infection
Seven days of antibiotics noninferior to 14 days for hospitalized patients with bloodstream infection
Integrative CBT for Prolonged Grief Beats Present-Centered Therapy
Significantly greater reductions seen in prolonged grief disorder severity after treatment; less depressive and psychopathological symptoms also reported
AI Algorithm Can ID Metabolic Dysfunction-Associated Steatotic Liver Disease
Estimated 88 percent accuracy seen using electronic health record data, with ability to identify patients not previously diagnosed
AHA: Variation Seen in Rates of SGLT2i Rx for Heart Failure, LVEF >40 Percent
Prescription rates increased from 2021 to 2023, but high variance seen between hospitals in the rate of prescriptions
AHA: Bumetanide Nasal Spray Statistically Bioequivalent to Oral Bumetanide
Nasal spray absorbed more rapidly than oral tablet and has comparable pharmacodynamic effects of diuresis and natriuresis
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
Authors say findings may be due to relative excess of thyroid hormone even when treatment is targeted to reference range goals
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay
AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide
More than 39 million U.S. adults qualify for indications other than weight management alone
AHA: Initial Catheter Ablation Beneficial for Ventricular Tachycardia
Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy
